$125.1 M

EYES Mkt cap, 20-Sep-2018

$2.9 M

Second Sight Medical Products Revenue Q2, 2018
Second Sight Medical Products Gross profit (Q2, 2018)1.4 M
Second Sight Medical Products Gross profit margin (Q2, 2018), %47.8%
Second Sight Medical Products Net income (Q2, 2018)-17.7 M
Second Sight Medical Products EBIT (Q2, 2018)-17.8 M
Second Sight Medical Products Cash, 30-Jun-20187.5 M

Second Sight Medical Products Revenue

Second Sight Medical Products revenue was $7.96 m in FY, 2017

Embed Graph

Second Sight Medical Products Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017

Revenue

9 m4 m8 m

Revenue growth, %

(55%)

Cost of goods sold

5.3 m10.1 m5.1 m

Gross profit

3.7 m(6.1 m)2.8 m

Gross profit Margin, %

41%(153%)36%

Sales and marketing expense

9.6 m

General and administrative expense

8.2 m10.1 m10.9 m

Operating expense total

8.2 m10.1 m31.5 m

EBIT

(20 m)(33.2 m)(28.6 m)

EBIT margin, %

(224%)(833%)(359%)

Interest income

2 k31 k93 k

Net Income

(20 m)(33.2 m)(28.5 m)

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

1.7 m2.7 m2.2 m1.1 k1 m1.2 m1 m2.2 m1.6 m976 k2.9 m

Cost of goods sold

1.3 m1.6 m757.1 k912 3.2 m2.6 m1.1 m1.1 m1 m668 k1.5 m

Gross profit

404.3 k1.1 m1.5 m141 (2.2 m)(1.4 m)(118 k)1.1 m609 k308 k1.4 m

Gross profit Margin, %

24%41%66%13%(213%)(122%)(12%)50%38%32%48%

Sales and marketing expense

3 m5.9 m

General and administrative expense

1.7 m2 m2.4 m2.4 k2.6 m2.6 m2.7 m2.9 m3.2 m5.9 m

Operating expense total

5.4 m6 m6.1 m6 k6.3 m7.1 m7.4 m8 m7.4 m10.1 m19.1 m

EBIT

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.6 m)(6.9 m)(6.7 m)(9.8 m)(17.8 m)

EBIT margin, %

(292%)(186%)(209%)(553%)(820%)(720%)(749%)(307%)(419%)(1001%)(616%)

Interest income

796 352 84 5 3 k11 k7 k29 k33 k16 k43 k

Net Income

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.5 m)(6.8 m)(6.7 m)(9.8 m)(17.7 m)

Second Sight Medical Products Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017

Cash

239 k539 k604 k

Accounts Receivable

1.5 m274 k1.8 m

Inventories

1.1 m717 k2.7 m

Current Assets

26.8 m15.3 m13.2 m

PP&E

1.4 m1.5 m1.3 m

Total Assets

28.2 m16.8 m14.5 m

Accounts Payable

710 k1.2 m752 k

Current Liabilities

8 m5.7 m6.6 m

Additional Paid-in Capital

27.3 m30.7 m40.5 m

Retained Earnings

(172.7 m)(205.9 m)(234.4 m)

Total Equity

20.3 m11.1 m7.9 m

Financial Leverage

1.4 x1.5 x1.8 x

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

652.3 k407.4 k268.7 k459 184 k277 k266 k763 k639 k5 m7.5 m

Accounts Receivable

1.3 m1.2 m1.3 m822 677 k447 k782 k926 k668 k475 k718 k

Inventories

6.4 m6.8 m8.1 m9.1 k7.4 m5.8 m3.1 m3.1 m462 k2.8 m3.6 m

Current Assets

38.4 m35.7 m31.9 m21.1 k32.5 m24.7 m28.6 m22.8 m17.7 m9.1 m12.4 m

PP&E

1 m1.1 m1.4 m1.4 k1.5 m1.5 m1.5 m1.4 m1.3 m1.2 m

Total Assets

39.5 m36.9 m33.3 m22.6 k34.1 m26.3 m30.1 m24.3 m19.1 m10.4 m13.6 m

Accounts Payable

414.4 k330.4 k544.4 k707 671 k694 k895 k558 k826 k1.6 m1.2 m

Current Liabilities

9 m8.8 m8.8 m6.6 k6 m5.7 m5.8 m5.5 m6.1 m6.9 m7.1 m

Additional Paid-in Capital

25.1 m25.7 m26.5 m28.3 k29 m29.9 m37.7 m38.7 m39.6 m41.8 m42.4 m

Retained Earnings

(157.6 m)(162.5 m)(167.2 m)(178.5 k)(187 m)(195.5 m)(213.4 m)(220.3 m)(227 m)(244.1 m)(252.1 m)

Total Equity

30.5 m28.1 m24.5 m15.9 k28.1 m20.6 m24.4 m18.8 m13 m3.5 m6.5 m

Financial Leverage

1.3 x1.3 x1.4 x1.4 x1.2 x1.3 x1.2 x1.3 x1.5 x2.9 x2.1 x

Second Sight Medical Products Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017

Net Income

(20 m)(33.2 m)(28.5 m)

Depreciation and Amortization

335 k432 k

Accounts Receivable

(793 k)955 k(1.4 m)

Inventories

(2.5 m)10 k3.9 m

Accounts Payable

197 k446 k(419 k)

Cash From Operating Activities

(20.5 m)(25.1 m)(23.9 m)

Purchases of PP&E

(762 k)(490 k)(265 k)

Cash From Investing Activities

17.5 m4.9 m2.8 m

Cash From Financing Activities

2.8 m20.5 m21.2 m

Quarterly

USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(5 m)(4.9 m)(4.7 m)(5.8 k)(8.5 m)(8.5 m)(7.5 m)(14.4 m)(6.7 m)(9.8 m)(17.7 m)

Depreciation and Amortization

111 k222 k

Accounts Receivable

1.3 m1.2 m1.3 m822 677 k447 k(454 k)(704 k)668 k1.4 m1.1 m

Inventories

1 m1.9 m462 k21 k(947 k)

Accounts Payable

414.4 k330.4 k544.4 k707 671 k694 k(269 k)(528 k)826 k857 k471 k

Cash From Operating Activities

(6.6 m)(12.6 m)(6.8 m)(14.6 m)

Purchases of PP&E

(89 k)(151 k)(68 k)(116 k)

Cash From Investing Activities

(7.2 m)(68 k)(116 k)

Cash From Financing Activities

19.7 m19.9 m4 m14.4 m

Second Sight Medical Products Ratios

USDY, 2018

Financial Leverage

2.1 x
Report incorrect company information

Second Sight Medical Products Operating Metrics

FY, 2016

Patents Issued

381

Patents Pending

126
Report incorrect company information